Marketing to and for investors
An investor is evaluating whether the market will believe you. That makes go-to-market a diligence item, and it makes marketing a way to remove risk from a bet.
What are investors actually evaluating in go-to-market?
Whether the market will believe the claim. They test if the category exists, whether anyone outside the company uses your language for the problem, whether growth came from a repeatable motion or a few relationships, and whether the story survives a customer call. Pipeline numbers matter less than whether the mechanism behind them is provable.
Founders tend to assume an investor conversation is about the product. Mostly it is about belief: conviction about what will happen, why it is inevitable, and whether the team is the right one to build it.
What are investors actually evaluating?
4 things, and only 1 of them is your numbers.
- Does the category exist, or are you the only one naming the problem this way?
- Did growth come from a repeatable motion, or from relationships that do not scale?
- Does the story hold up on a reference call, said by someone who does not work for you?
- Is there a defensible answer to why now?
How does marketing help a raise?
By removing doubt.
At the same revenue, 2 companies raise differently depending on whether the market has language for what they do. Analyst recognition, an adopted category term, named references and a story that stays consistent across the site, the deck and the sales call all lower the perceived risk. None of it replaces revenue. All of it changes how the revenue reads.
What kills a round?
Uncertainty nobody has shaped. A category nobody else names. Growth that traces to the founder’s network. A message that shifts between the homepage and the demo. A market-size slide with no argument for urgency.
Investors do not need you to be finished. They need the unknowns to be defined, with a path to define them.
What does this look like on the fund side?
Portfolio companies stall in predictable places: an unnamed category, a founder-dependent motion, no analyst relationship, a message never tested against a security review.
Those patterns repeat, which makes them worth diagnosing the same way each time. We do diligence support before a deal and positioning work after one.
Supporting reading
- Marketing for investors: de-risking a security bet and readying a company to raise or exit.Investors · 5 min
- How to position your cybersecurity startup to investors.Positioning · 8 min
- Founder intuition is a hypothesis. Test it before you fund it.Operating · 4 min
- An embarrassment of opportunity.Operating · 5 min
What people ask
What do investors look for in a security company's go-to-market?
Evidence that the market will believe the claim. Does the category exist, does anyone outside the company use your language for the problem, did growth come from a repeatable motion or a handful of relationships, and does the story survive a reference call. A mechanism they can understand beats a bigger number they cannot.
How is marketing to investors different from marketing to buyers?
A buyer asks whether this solves their problem. An investor asks whether enough buyers will conclude that, fast enough, and whether this team can make that happen. The first needs proof of value; the second needs proof of a repeatable motion and a market that is forming rather than crowded.
Can marketing help a company raise?
Yes, in a specific way: by removing doubt. Analyst recognition, an adopted category term, named references, and a coherent public narrative all reduce the perceived risk of the bet. None of it substitutes for revenue, but at the same revenue two companies raise differently depending on whether the market has vocabulary for what they do.
What go-to-market problems kill rounds?
A category nobody else names, growth that traces to founder relationships rather than a motion, a message that changes between the website and the sales call, and no answer to why now. Each reads as unquantifiable risk, which is worse to an investor than a known weakness.
How do investors use marketing across a portfolio?
To make the same mistake fewer times. Positioning, category, and analyst work are the areas where portfolio companies most reliably stall, and where shared diligence patterns and a named method transfer well between companies.
Investor work sits in the Opportunity and Proof phases of OPSI. The audience is the investor, the outcome is a funded bet, and the evidence standard is set by someone whose job is to find the flaw. Related: positioning, category creation, and analyst relations.